In one of the first examinations of PSA screening in younger men, a study published by researchers at Duke Medicine's Prostate Center finds that one-fifth of men under age 50 reported undergoing a prostate specific antigen (PSA) test to detect

The popular sleeping pill Stilnox now carries a warning about the potentially dangerous sleep-related behaviours linked to the drug.

In a study on fetal alcohol syndrome, researchers were able to prevent the damage that alcohol causes to cells in a key area of the fetal brain by blocking acid sensitive potassium channels and preventing the acidic environment that alcohol

The health of people who never marry is improving, narrowing the gap with their wedded counterparts, according to new research that suggests the practice of encouraging marriage to promote health may be misguided.

LONDON (AFP) - Virgin Atlantic boss Richard Branson has written to US presidential candidates Barack Obama and John McCain to warn against a potential alliance between British Airways and American Airlines, it emerged Monday.

Researchers from the Indiana University School of Medicine, the Regenstrief Institute and Moi University School of Medicine are the first to report that adherence to antiretroviral therapy (ART) to fight human immunodeficiency virus (HIV) in children who live in low

Over £500,000 has been awarded to Bristol University academics to fund research into how stress hormones act in the brain.

When dividing cells copy their DNA, mistakes can - and do - occur. To compensate, cells have a built-in system to correct these errors. That correction process isn't thoroughly understood, but researchers are piecing it together bit by bit.

The Consortium for Southeastern Hypertension Control (COSEHC), which is headquartered at Wake Forest University Baptist Medical Center, has received a $55,000 grant from the Blue Cross and Blue Shield of North Carolina Foundation to provide a mobile cardiovascular disease prevention

NEW YORK (AFP) - Crude oil prices sank Monday as the market worried about weakening demand, particularly in the eurozone and in China, after Chinese oil imports fell sharply.

NanoViricides, Inc. said that additional biological tests and data analysis have shown that animals treated with its lead anti-HIV drug candidate, HIVCide-I, demonstrated a substantially greater reduction in viral load -- number of infectious virus particles per milliliter of blood

For patients with clogged heart arteries who take long-term, low-dose aspirin to prevent a cardiac event, adding a stomach acid-blocking drug to their daily routine has been shown to reduce their risk for upper gastrointestinal bleeding - an infrequent, but

Small, specially designed bits of ribonucleic acid (RNA) can interfere with cholesterol metabolism, reducing harmful cholesterol by two-thirds in pre-clinical tests, according to a new study by researchers at UT Southwestern Medical Center in collaboration with Alnylam Pharmaceuticals and the

Convenience and lower costs are driving even more parents to seek routine health care for their children - including vaccinations and physicals - at retail clinics in their communities.

Prions, the pathogens that cause scrapie in sheep, can survive in the ground for several years, as researchers have discovered. Animals can become infected via contaminated pastures. It is not yet known whether the pathogens that cause BSE and CWD

Researchers at the University of Newcastle, England, and the Virginia Bioinformatics Institute at Virginia Tech in the United States have revealed a large reservoir of mitochondrial DNA mutations present in the general population. Clinical analysis of blood samples from almost

Researchers at Johns Hopkins are reporting what is believed to be the most conclusive evidence to date that inadequate levels of vitamin D, obtained from milk, fortified cereals and exposure to sunlight, lead to substantially increased risk of death.

when acted on by a known mutant, cancer-causing oncogene, say researchers from Dana-Farber Cancer Institute and the University of California, San Francisco (UCSF).

A team of Monash University researchers has uncovered the role of a family of enzymes in the mutation of benign or less aggressive tumours into more aggressive, potentially fatal, cancers in the human body.

Scientists from the Gladstone Institute of Cardiovascular Disease (GICD) and UCSF have identified a key regulatory factor that controls development of the human vascular system, the extensive network of arteries, veins, and capillaries that allow blood to reach all tissues